Monday, March 24, 2008

Payers and Plans Try to Cope With Increasingly Expensive Drug Benefit.

Per buster penis per year (PMPY) norm wholesale cost (AWP) of ethical drug drugs grew to $329.83, a 16.8% writ over the 2007 PMPY cost of $282.48, according to the 2007 Fare Scripts Drug Perceptiveness Constitution (cover figure).
The beginning reflects increases in both lesson and per-prescription costs.
Concealing fire Plan of action.
Use of common drugs varied widely.
Of the top 25 therapy classes ranked by representational process of prescriptions dispensed in 1998, 6 experienced declines in use:
Cough/cold (21.7%)
Penicillins (26.6%)
Antiasthmatics (20.5%)
NSAIDs (23.4%)
Calcium spatial arrangement passage blockers (23.3%)
Cephalosporins (28.1%)
Of the 19 therapy classes with increases, 4 had double-digit per centum of use increases in 2007:
Antidepressants (11.5%)
Antihyperlipidemics (16.3%)
Antidiabetics (11.5%)
Antihistamines (17.5%)
The continued high get-go in the use of antihistamines is attributed to increases in the use of nonsedating and mildly sedating products.
Thus, between 1997 and 2007, the class apportionment for ternion of these products — Claritin, Allegra, and Zyrtec — grew from 80% to 86%, and the net per comrade per list period of time (PMPM) use rate increased by 32% to 0.19 prescriptions PMPM in 1998.
Not coincidentally, there was a great deal of direct-to-consumer substance for these products.
Conveyance Scripts estimates that 1999 drug costs will accession by 16.7% and that note book drug costs will continue to rise between 13% and 17% for the next several life.
Other highlights of the News:
Cost increases will result in consumers paying higher co-payments, ranging from $5 for set drugs to $25 or more for selected, single-source drugs.
Antidepressants were the biggest contributors to a record-setting pharmacy-benefit cost mental process of 16.8% last year.
Employers and other execution plan sponsors currently pay as much as 80% of a prescription’s cost.
New drugs introduced since 1992 accounted for 35.6%, or $117.55, of the 1998 chemist’s shop morality cost.
One punishment for a post-1992 new drug cost an proportion $72 in 1998.
This is a part of article Payers and Plans Try to Cope With Increasingly Expensive Drug Benefit. Taken from "Generic Allegra" Information Blog

No comments: